Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
CeriBell, Inc. (CBLL)
Company Research
Source: GlobeNewswire
SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming Piper Sandler 37th Annual Healthcare Conference in New York. The presentation will take place on Wednesday, December 3, 2025, at 6:10 a.m. Pacific Standard Time / 9:10 a.m. Eastern Standard Time. Event: Piper Sandler 37th Annual Healthcare ConferenceDate: Wednesday, December 3, 2025Time: 6:10 a.m. PST / 9:10 a.m. EST A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/. About CeriBell, Inc. Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ce
Show less
Read more
Impact Snapshot
Event Time:
CBLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CBLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CBLL alerts
High impacting CeriBell, Inc. news events
Weekly update
A roundup of the hottest topics
CBLL
News
- Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for NeonatesGlobeNewswire
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswire
- CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $17.00. They now have an "overweight" rating on the stock.MarketBeat
- CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at TD Cowen from $36.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- Ceribell Reports Third Quarter 2025 Financial ResultsGlobeNewswire
CBLL
Earnings
- 11/4/25 - Beat
CBLL
Sec Filings
- 12/5/25 - Form 4
- 12/4/25 - Form 144
- 12/4/25 - Form 4
- CBLL's page on the SEC website